These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8871670)
41. Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation. Swaminathan S; Qiu J; Rupert AW; Hu Z; Higgins J; Dewar RL; Stevens R; Rehm CA; Metcalf JA; Sherman BT; Baseler MW; Lane HC; Imamichi T PLoS One; 2016; 11(11):e0167091. PubMed ID: 27880829 [TBL] [Abstract][Full Text] [Related]
42. Effect of Anti-IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques. DeGottardi MQ; Okoye AA; Vaidya M; Talla A; Konfe AL; Reyes MD; Clock JA; Duell DM; Legasse AW; Sabnis A; Park BS; Axthelm MK; Estes JD; Reiman KA; Sekaly RP; Picker LJ J Immunol; 2016 Aug; 197(4):1183-98. PubMed ID: 27430715 [TBL] [Abstract][Full Text] [Related]
43. Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection. Haas A; Zimmermann K; Oxenius A J Virol; 2011 Dec; 85(23):12102-13. PubMed ID: 21849433 [TBL] [Abstract][Full Text] [Related]
44. IL-15 ex vivo overcomes CD4+ T cell deficiency for the induction of human antigen-specific CD8+ T cell responses. Yu H; Tawab-Amiri A; Dzutsev A; Sabatino M; Aleman K; Yarchoan R; Terabe M; Sui Y; Berzofsky JA J Leukoc Biol; 2011 Jul; 90(1):205-14. PubMed ID: 21474552 [TBL] [Abstract][Full Text] [Related]
45. Generation of effector CD8+ T cells and their conversion to memory T cells. Cui W; Kaech SM Immunol Rev; 2010 Jul; 236():151-66. PubMed ID: 20636815 [TBL] [Abstract][Full Text] [Related]
46. Regulation of the induction and function of cytotoxic T lymphocytes by natural killer T cell. Ito H; Seishima M J Biomed Biotechnol; 2010; 2010():641757. PubMed ID: 20508728 [TBL] [Abstract][Full Text] [Related]
48. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. Mueller YM; Do DH; Altork SR; Artlett CM; Gracely EJ; Katsetos CD; Legido A; Villinger F; Altman JD; Brown CR; Lewis MG; Katsikis PD J Immunol; 2008 Jan; 180(1):350-60. PubMed ID: 18097036 [TBL] [Abstract][Full Text] [Related]
49. Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery. Kowalczyk A; Wierzbicki A; Gil M; Bambach B; Kaneko Y; Rokita H; Repasky E; Fenstermaker R; Brecher M; Ciesielski M; Kozbor D Cancer Immunol Immunother; 2007 Sep; 56(9):1443-58. PubMed ID: 17597331 [TBL] [Abstract][Full Text] [Related]
50. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. Miles DJ; van der Sande M; Jeffries D; Kaye S; Ismaili J; Ojuola O; Sanneh M; Touray ES; Waight P; Rowland-Jones S; Whittle H; Marchant A J Virol; 2007 Jun; 81(11):5766-76. PubMed ID: 17376923 [TBL] [Abstract][Full Text] [Related]
51. Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery. Bolesta E; Kowalczyk A; Wierzbicki A; Eppolito C; Kaneko Y; Takiguchi M; Stamatatos L; Shrikant PA; Kozbor D J Immunol; 2006 Jul; 177(1):177-91. PubMed ID: 16785513 [TBL] [Abstract][Full Text] [Related]
52. Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques. Mueller YM; Petrovas C; Bojczuk PM; Dimitriou ID; Beer B; Silvera P; Villinger F; Cairns JS; Gracely EJ; Lewis MG; Katsikis PD J Virol; 2005 Apr; 79(8):4877-85. PubMed ID: 15795273 [TBL] [Abstract][Full Text] [Related]
54. Studies on the production of IL-15 in HIV-infected/AIDS patients. Ahmad R; Sindhu ST; Toma E; Morisset R; Ahmad A J Clin Immunol; 2003 Mar; 23(2):81-90. PubMed ID: 12757260 [TBL] [Abstract][Full Text] [Related]
55. High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection. Ahlers JD; Belyakov IM; Thomas EK; Berzofsky JA J Clin Invest; 2001 Dec; 108(11):1677-85. PubMed ID: 11733563 [TBL] [Abstract][Full Text] [Related]
56. Activation, survival and apoptosis of CD45RO+ and CD45RO- T cells of human immunodeficiency virus-infected individuals: effects of interleukin-15 and comparison with interleukin-2. Naora H; Gougeon M Immunology; 1999 Jun; 97(2):181-7. PubMed ID: 10447730 [TBL] [Abstract][Full Text] [Related]
57. Effect of interleukin (IL)-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection. Lin SJ; Roberts RL; Ank BJ; Nguyen QH; Thomas EK; Stiehm ER J Clin Immunol; 1998 Sep; 18(5):335-45. PubMed ID: 9793826 [TBL] [Abstract][Full Text] [Related]
58. IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Kivisäkk P; Matusevicius D; He B; Söderström M; Fredrikson S; Link H Clin Exp Immunol; 1998 Jan; 111(1):193-7. PubMed ID: 9472681 [TBL] [Abstract][Full Text] [Related]
59. IL-15 stimulates the expansion of AIDS virus-specific CTL. Kanai T; Thomas EK; Yasutomi Y; Letvin NL J Immunol; 1996 Oct; 157(8):3681-7. PubMed ID: 8871670 [TBL] [Abstract][Full Text] [Related]
60. A MHC class I B locus allele-restricted simian immunodeficiency virus envelope CTL epitope in rhesus monkeys. Yasutomi Y; McAdam SN; Boyson JE; Piekarczyk MS; Watkins DI; Letvin NL J Immunol; 1995 Mar; 154(5):2516-22. PubMed ID: 7532670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]